Concepedia

Publication | Open Access

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

252

Citations

29

References

2007

Year

Abstract

Single-agent doxorubicin remains the treatment of choice for patients with advanced soft tissue sarcoma.

References

YearCitations

Page 1